Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Farmers Insurance
Cerilliant
Federal Trade Commission
Citi
Medtronic
QuintilesIMS
Queensland Health

Generated: January 24, 2019

DrugPatentWatch Database Preview

Chlorpromazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for chlorpromazine hydrochloride and what is the scope of chlorpromazine hydrochloride freedom to operate?

Chlorpromazine hydrochloride is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Actavis Mid Atlantic, Pharm Assoc, Wockhardt, Cycle Pharms Ltd, Fosun Pharma, Abraxis Pharm, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Amneal Pharms Co, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Purepac Pharm, Pvt Form, Sandoz, Usl Pharma, Vangard, West Ward, and Parke Davis, and is included in sixty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for chlorpromazine hydrochloride. Fourteen suppliers are listed for this compound.

Pharmacology for chlorpromazine hydrochloride
Drug ClassPhenothiazine

US Patents and Regulatory Information for chlorpromazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fosun Pharma SONAZINE chlorpromazine hydrochloride SYRUP;ORAL 083040-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 085960-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline THORAZINE chlorpromazine hydrochloride TABLET;ORAL 009149-020 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cycle Pharms Ltd CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 085331-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride INJECTABLE;INJECTION 083329-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cycle Pharms Ltd CHLORPROMAZINE HYDROCHLORIDE INTENSOL chlorpromazine hydrochloride CONCENTRATE;ORAL 088157-001 Apr 27, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abraxis Pharm CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride INJECTABLE;INJECTION 084911-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
McKesson
Cantor Fitzgerald
Julphar
US Department of Justice
Medtronic
Fish and Richardson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.